News
22d
Zacks Investment Research on MSNCan LLY's Next-Generation Obesity Pipeline Fuel Further Growth?Despite being on the market for less than three years, GLP-1 medicines, Mounjaro and Zepbound, became key top-line drivers for Lilly, with demand rising rapidly.However, to maintain its prowess in the ...
Dr. Aronne said the dual-action approach of tirzepatide is likely the reason for its stronger results. “Although it is a single molecule, tirzepatide pharmacologically activates two metabolic ...
Small-molecule technology could soon make easy-to-take GLP-1 pills a reality. ... Rodriguez PJ et al. Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity.
Nimacimab shows comparable weight loss to monlunabant and tirzepatide alone, and an additive effect in combination with tirzepatide, in diet-induced obesity model New in vitro data demonstrates ...
A new study compared the effectiveness of weight-loss drugs tirzepatide and semaglutide, finding tirzepatide leads to greater weight loss and waist reduction. Doctors shared insights.
Hosted on MSN3mon
Why Hims & Hers Health Stock Couldn't Beat the Market TodayUndaunted, on Tuesday, Hims & Hers announced it is to offer branded versions of tirzepatide-- the molecule in the other FDA-approved obesity jab, Eli Lilly's Zepbound.
BOSTON and SHANGHAI, June 17, 2025 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic ...
A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in adults with obesity but without diabetes. Over 72 weeks, tirzepatide ...
Tirzepatide also had meaningful and significant effects on health status, exercise tolerance, and systemic inflammation. "SUMMIT is the first trial in patients with HFpEF and obesity that had ...
Researchers collected data from the five SURPASS trials, which assessed the effects of tirzepatide among people with type 2 diabetes. Tirzepatide was compared with placebo in SURPASS-1 and SURPASS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results